Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment-Reference-Cited by-同舟云学术

Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment

Published:2022-11-24 Issue:1 Volume:12 Page:193-207
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Yoshimura Kosuke^ORCID,Ohge Hiroki,Ikawa Kazuro,Uegami Shinnosuke,Watadani Yusuke,Shigemoto Norifumi,Hirano Toshinori,Kitagawa Hiroki,Kaiki Yuki,Morikawa Norifumi,Takahashi Shinya

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-022-00720-x.pdf

Reference34 articles.

1. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133–64. https://doi.org/10.1086/649554.

2. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72:2145–55. https://doi.org/10.1093/jac/dkx146.

3. Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, et al. Verification of ceftazidime–avibactam and ceftolozane–tazobactam susceptibility testing methods against carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2018;56:e01093-e1117. https://doi.org/10.1128/JCM.01093-17.

4. Toussaint KA, Gallagher JC. β-Lactam/β-lactamase inhibitor combinations: from then to now. Ann Pharmacother. 2015;49:86–98. https://doi.org/10.1177/1060028014556652.

5. Castanheira M, Duncan LR, Mendes RE, Sader HS, Shortridge D. Activity of ceftolozane–tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates collected from respiratory tract specimens of hospitalized patients in the United States during 2013 to 2015. Antimicrob Agents Chemother. 2018;62:e02125-e2217. https://doi.org/10.1128/AAC.02125-17.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review;Frontiers in Antibiotics;2024-06-17